Viking Global Investors
EWTX icon

Viking Global Investors’s Edgewise Therapeutics EWTX Stock Holding History

Viking Global Investors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-490,035
Closed -$10.8M – 91
2025
Q1 		$10.8M Sell
490,035
-734,951
-60% -$19.3M 0.03% 87
2024
Q4 		$32.7M Sell
1,224,986
-256,160
-17% -$8.16M 0.11% 80
2024
Q3 		$39.5M Hold
1,481,146
– – 0.14% 76
2024
Q2 		$26.7M Sell
1,481,146
-1,858,000
-56% -$32.4M 0.1% 77
2024
Q1 		$60.9M Sell
3,339,146
-2,820,000
-46% -$44.8M 0.23% 69
2023
Q4 		$67.4M Hold
6,159,146
– – 0.25% 64
2023
Q3 		$35.3M Buy
6,159,146
+215,885
+4% +$1.47M 0.14% 70
2023
Q2 		$46.1M Buy
5,943,261
+1,034,115
+21% +$8.72M 0.19% 75
2023
Q1 		$32.7M Buy
4,909,146
+500,000
+11% +$4.63M 0.15% 69
2022
Q4 		$39.4M Hold
4,409,146
– – 0.2% 65
2022
Q3 		$43.4M Buy
4,409,146
+1,681,897
+62% +$17M 0.2% 71
2022
Q2 		$21.7M Hold
2,727,249
– – 0.1% 77
2022
Q1 		$26.5M Hold
2,727,249
– – 0.11% 82
2021
Q4 		$41.7M Hold
2,727,249
– – 0.12% 89
2021
Q3 		$45.3M Hold
2,727,249
– – 0.12% 83
2021
Q2 		$58.2M Sell
2,727,249
-625,000
-19% -$17.1M 0.18% 73
2021
Q1 		$109M Buy
+3,352,249
New +$109M 0.32% 64

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Viking Global Investors's EWTX Position: Q2 2025 in Review

Viking Global Investors sold out of Edgewise Therapeutics (EWTX) in Q2 2025, closing a stake of 490,035 shares — an estimated $10.8M sold.

Viking Global Investors first reported a position in EWTX in Q1 2021 and held it in 17 quarters. The position peaked at $109M in Q1 2021. 178 funds tracked by Wall St. Rank hold EWTX as of Q2 2025.

  • Viking Global Investors reported no remaining Edgewise Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Viking Global Investors sold 490,035 Edgewise Therapeutics shares in Q2 2025, an estimated $10.8M.
  • Viking Global Investors first reported a position in Edgewise Therapeutics in Q1 2021 and held it in 17 quarters.
  • Viking Global Investors's Edgewise Therapeutics position peaked at $109M in Q1 2021.
  • 178 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2025.

Based on Viking Global Investors's 13F filing for Q2 2025, filed 14 Aug 2025.